DA
HQL
Doliver Advisors’s abrdn Life Sciences Investors HQL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-12,136
| Closed | -$212K | – | 185 |
|
|
2020
Q1 | $212K | Sell |
12,136
-14,734
| -55% | -$257K | 0.1% | 111 |
|
|
2019
Q4 | $468K | Buy |
26,870
+10,048
| +60% | +$175K | 0.19% | 55 |
|
|
2019
Q3 | $255K | Buy |
+16,822
| New | +$255K | 0.1% | 88 |
|
|
2018
Q3 | – | Sell |
-33,626
| Closed | -$632K | – | 240 |
|
|
2018
Q2 | $632K | Buy |
33,626
+18,990
| +130% | +$357K | 0.26% | 58 |
|
|
2018
Q1 | $281K | Sell |
14,636
-3,186
| -18% | -$61.2K | 0.12% | 158 |
|
|
2017
Q4 | $350K | Buy |
+17,822
| New | +$350K | 0.14% | 121 |
|
|
2017
Q1 | – | Sell |
-25,493
| Closed | -$433K | – | 253 |
|
|
2016
Q4 | $433K | Sell |
25,493
-32,648
| -56% | -$555K | 0.37% | 92 |
|
|
2016
Q3 | $1.09M | Buy |
58,141
+26,063
| +81% | +$488K | 0.92% | 38 |
|
|
2016
Q2 | $565K | Sell |
32,078
-61,972
| -66% | -$1.09M | 0.48% | 68 |
|
|
2016
Q1 | $1.69M | Buy |
94,050
+53,486
| +132% | +$959K | 1.49% | 20 |
|
|
2015
Q4 | $959K | Sell |
40,564
-7,899
| -16% | -$187K | 0.76% | 47 |
|
|
2015
Q3 | $1.09M | Buy |
+48,463
| New | +$1.09M | 0.81% | 40 |
|
|
2015
Q2 | – | Sell |
-50,373
| Closed | -$1.39M | – | 300 |
|
|
2015
Q1 | $1.39M | Buy |
50,373
+21,716
| +76% | +$599K | 0.89% | 23 |
|
|
2014
Q4 | $712K | Buy |
28,657
+1,961
| +7% | +$48.7K | 0.5% | 68 |
|
|
2014
Q3 | $590K | Buy |
+26,696
| New | +$590K | 0.41% | 94 |
|